Michael Graves's Net Worth
-$47.7 Thousand
Who is Michael Graves?
Michael Graves does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EAGLE PHARMACEUTICALS, INC., and PAR PHARMACEUTICAL COMPANIES, INC..
SEC CIK
Michael Graves's CIK is 0001339978
Past Insider Trading and Trends
2016 was Michael Graves's most active year for acquiring shares with 3 total transactions. Michael Graves's most active month to acquire stocks was the month of December. 2023 was Michael Graves's most active year for disposing of shares, totalling 1 transactions. Michael Graves's most active month to dispose stocks was the month of September. 2016 saw Michael Graves paying a total of $56,730.00 for 31,000 shares, this is the most they've acquired in one year. In 2023 Michael Graves cashed out on 9,360 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EAGLE PHARMACEUTICALS, INC. (EGRX) Snapshot price: $5.33
Interim Executive Chair & PEOMichael Graves owns 10,360 units of Common Stock which is worth $55,218.80. From 2014 to 2023 Michael Graves acquired a total of 10,360 shares in EAGLE PHARMACEUTICALS, INC. at a cost of $102,968.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
| +936.00% | 9.36K |
$4.94 | $46,238.40 | 10.36K |
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
|
∞
| 1K |
$56.73 | $56,730.00 | 1K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PAR PHARMACEUTICAL COMPANIES, INC. No price found
Pres, Generic Products DivMichael Graves owns 37,869 units of Restricted Stock.acquired a total of 19,838 shares in PAR PHARMACEUTICAL COMPANIES, INC..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +110.02% | 19.84K |
—
|
—
| 37.87K |
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||